Diagnologix
Biotechnology, Huennekens St Ste 206, San Diego, , 92121, California, 10179, United States, 1-10 Employees
Who is DIAGNOLOGIX
Diagnologix pioneers in cell-processing systems to sort, isolate, and manipulate stem cells, immune cells and circulating tumor cells, in bulk-volume biological fluids (e.g. blood) for re...
Read More
-
Headquarters: 10179 Huennekens St Ste 206, San Diego, California, 92121, United States
-
Date Founded: 2012
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from DIAGNOLOGIX
Diagnologix Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Diagnologix
Answer: Diagnologix's headquarters are located at Huennekens St Ste 206, San Diego, , 92121, California, 10179, United States
Answer: Diagnologix's official website is https://diagnologix.com
Answer: Diagnologix's revenue is Under $1 Million
Answer: Diagnologix's SIC: 8731
Answer: Diagnologix has 1-10 employees
Answer: Diagnologix is in Biotechnology
Answer: Diagnologix contact info: Phone number: Website: https://diagnologix.com
Answer: Diagnologix pioneers in cell-processing systems to sort, isolate, and manipulate stem cells, immune cells and circulating tumor cells, in bulk-volume biological fluids (e.g. blood) for research and clinical applications. Diagnologix repurposes the lipid shelled perfluorocarbon-filled microbubble (MB), which has been approved by the FDA as an ultrasound contrast agent, as a self-driving vehicle for cell separation and as a tunable artificial cell for target-cell regulation. Diagnologix has filed two series of world-wide patent applications and has been granted two US patents and 2 international patents in 2019. One current focus is on streamlining the workflow for sorting and expanding the naive T cells, to overcome clinical bottlenecks of cell processing and production, including CAR-T cell manufacturing. Diagnologix will accomplish a scalable and closed cell manufacturing system (BUBLES), which assembles all cell processing steps including isolation of specific T cell types to subsequent cell activation and expansion in a single unit. This innovation can substantially lower the cost of cell manufacturing and potentially decentralize CAR-T cell production, therefore, to benefit more patients.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Powered by
Sign in to CIENCE GO Data to uncover contact details
Free credits every month